Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models
- 28 February 2005
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (2) , 120-129
- https://doi.org/10.1016/j.ijantimicag.2004.09.012
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- PK–PD modelling of the effect of cefaclor on four different bacterial strainsInternational Journal of Antimicrobial Agents, 2004
- Interstitial tissue concentrations of cefpodoximeJournal of Antimicrobial Chemotherapy, 2002
- Comparative Target Site Pharmacokinetics of Immediate- and Modified-Release Formulations of Cefaclor in HumansThe Journal of Clinical Pharmacology, 2002
- Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusionAntimicrobial Agents and Chemotherapy, 1997
- Comparison of Cefprozil, Cefpodoxime Proxetil, Loracarbef, Cefixime, and CeftibutenAnnals of Pharmacotherapy, 1996
- Pharmacokinetic-Pharmacodynamic Modeling of the Antibiotic Effect of Piperacillin in VitroPharmaceutical Research, 1996
- In-vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 1990
- Differences between bacteria grown in vitro and in vivoJournal of Antimicrobial Chemotherapy, 1985
- Comparative analysis of the antimicrobial action of polymorphonuclear leucocytes in vitro, ex vivo and in vivoJournal of Antimicrobial Chemotherapy, 1985